CYDY
Price
$0.23
Change
-$0.01 (-4.17%)
Updated
Apr 24 closing price
Capitalization
284.08M
5 days until earnings call
HUMA
Price
$1.45
Change
-$0.03 (-2.03%)
Updated
Apr 25, 02:31 PM (EDT)
Capitalization
229.58M
14 days until earnings call
Ad is loading...

CYDY vs HUMA

Header iconCYDY vs HUMA Comparison
Open Charts CYDY vs HUMABanner chart's image
CytoDyn
Price$0.23
Change-$0.01 (-4.17%)
Volume$3.14M
Capitalization284.08M
Humacyte
Price$1.45
Change-$0.03 (-2.03%)
Volume$691
Capitalization229.58M
CYDY vs HUMA Comparison Chart
Loading...
CYDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYDY vs. HUMA commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYDY is a Hold and HUMA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (CYDY: $0.23 vs. HUMA: $1.48)
Brand notoriety: CYDY and HUMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYDY: 114% vs. HUMA: 46%
Market capitalization -- CYDY: $284.08M vs. HUMA: $229.58M
CYDY [@Biotechnology] is valued at $284.08M. HUMA’s [@Biotechnology] market capitalization is $229.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYDY’s FA Score shows that 1 FA rating(s) are green whileHUMA’s FA Score has 0 green FA rating(s).

  • CYDY’s FA Score: 1 green, 4 red.
  • HUMA’s FA Score: 0 green, 5 red.
According to our system of comparison, CYDY is a better buy in the long-term than HUMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYDY’s TA Score shows that 3 TA indicator(s) are bullish while HUMA’s TA Score has 4 bullish TA indicator(s).

  • CYDY’s TA Score: 3 bullish, 6 bearish.
  • HUMA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, HUMA is a better buy in the short-term than CYDY.

Price Growth

CYDY (@Biotechnology) experienced а +12.99% price change this week, while HUMA (@Biotechnology) price change was -11.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.17%. For the same industry, the average monthly price growth was -4.24%, and the average quarterly price growth was -12.55%.

Reported Earning Dates

CYDY is expected to report earnings on Apr 30, 2025.

HUMA is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+7.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYDY($284M) has a higher market cap than HUMA($230M). CYDY YTD gains are higher at: 110.118 vs. HUMA (-70.693). CYDY has higher annual earnings (EBITDA): -8.83M vs. HUMA (-137.16M). CYDY (21.3M) and HUMA (20.6M) have equal amount of cash in the bank . HUMA has less debt than CYDY: HUMA (17.3M) vs CYDY (28.7M). CYDY (0) and HUMA (0) have equivalent revenues.
CYDYHUMACYDY / HUMA
Capitalization284M230M123%
EBITDA-8.83M-137.16M6%
Gain YTD110.118-70.693-156%
P/E RatioN/AN/A-
Revenue00-
Total Cash21.3M20.6M103%
Total Debt28.7M17.3M166%
FUNDAMENTALS RATINGS
CYDY: Fundamental Ratings
CYDY
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYDYHUMA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
CYDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAMEX19.120.38
+2.03%
MoA Mid Cap Equity Index Fund
CBEJX9.93N/A
N/A
Allspring Large Cap Value CL R6
LHCQX17.36N/A
N/A
Lord Abbett Health Care R3
FASDX16.27N/A
N/A
Fidelity Advisor Strategic Div & Inc A
IRSSX12.04N/A
N/A
Voya Russell Small Cap Index Port S

CYDY and

Correlation & Price change

A.I.dvisor tells us that CYDY and LVTX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYDY and LVTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYDY
1D Price
Change %
CYDY100%
-3.31%
LVTX - CYDY
32%
Poorly correlated
+1.47%
AGNPF - CYDY
24%
Poorly correlated
N/A
HUMA - CYDY
21%
Poorly correlated
+0.68%
GNMSF - CYDY
14%
Poorly correlated
+2.14%
BMNDF - CYDY
12%
Poorly correlated
N/A
More

HUMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HUMA has been loosely correlated with RXRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if HUMA jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HUMA
1D Price
Change %
HUMA100%
+0.68%
RXRX - HUMA
41%
Loosely correlated
+3.05%
AURA - HUMA
39%
Loosely correlated
-4.17%
KYMR - HUMA
37%
Loosely correlated
+9.32%
TRDA - HUMA
36%
Loosely correlated
+2.87%
XERS - HUMA
36%
Loosely correlated
+3.63%
More